three hundred twenty-six patients with acute myelocytic leukemia were randomly and prospectively assigned to four therapeutic regimens : cytosine arabinoside either alone or in combination with daunorubicin , 6-mercaptopurine , or 6-thioguanine .
C0023467
acute myelocytic leukemia
C0011015
daunorubicin